Form D · Pharmaceuticals

Artax Biopharma, Inc.

Cambridge, MA · CIK 0001587661

Offering snapshot reported May 5, 2026 · SEC filing

Reported sold
$19M
Offering amount: $19M
Investors reported
30
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jul 31, 2024
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$9.5M$19MAug 9, 2024: $6,000,000.00Aug 9, 2024Jul 29, 2025: $11,000,000.00Jul 29, 2025May 5, 2026: $19,000,000.00May 5, 2026

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$11,000,000 → $19,000,000

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
May 5, 2026Amendment$19,000,000$8,000,000vs Jul 29, 202530SEC filing
Jul 29, 2025Amendment$11,000,000$5,000,000vs Aug 9, 202430SEC filing
Aug 9, 2024Initial$6,000,000No comparison24SEC filing
May 18, 2022Amendment$25,785,117$13,098,792vs Jan 3, 202228SEC filing
Jan 3, 2022Initial$12,686,325No comparison25SEC filing
Feb 26, 2021Initial$2,155,015No comparison19SEC filing
May 4, 2020Initial$2,000,000No comparison9SEC filing
Aug 12, 2019Initial$750,000No comparison24SEC filing
Oct 27, 2015Initial$3,000,000No comparison29SEC filing
Nov 10, 2014Initial$2,007,827No comparison18SEC filing
Sep 25, 2013Initial$1,268,256No comparison19SEC filing

Offering details

Securities
Debt, Option to acquire
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-521098

Source: Form D, filed May 5, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Robert Armstrong Director, Executive
Robert W. Armstrong, Ph.D. Director, Executive
Casper Breum Director
Jan De Vries, Ph.D. Director
Peter B. Finn Executive
Javier Garcia Director
Andre Hoekema Director
Joseph M. Lobacki Director, Executive
Maria Nichol Executive
Raj Parekh Director
Gino Santini Director
Joe Suarez Executive
Henri Termeer Director
Damia Tormo Director
Damia Tormo, Ph.D. Director
Damia Tormo, Ph.D., Mbm Director, Executive
Alan Walts Director

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
One Broadway 14 Th Floor
Cambridge, MA, 02142
Phone: 617-368-0676